News

NuGEN claimed that its cGMP certification, which complements the company’s ISO 13485 compliance, proves NuGEN’s infrastructure and its ability to develop and manufacture reproducible genomic sample preparation products.

Preliminary results of Canakinumab were presented at the annual European League Against Rheumatism (EULAR) meeting in Rome, Italy. In the six month Phase II study, Canakinumab has reduced

Zenpep is an FDA-approved pancreatic enzyme product (PEP) used for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) or other conditions. Zenpep has

Taspoglutide, a once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen’s research is developed by Roche, which is similar to the natural hormone

Vitrolife is acquiring 25% of the shares of HertART, with an option to acquire up to 100%. The purchase sum amounts to DKK 2m. For the Vitrolife Group

Jevtana, a microtubule inhibitor, in combination with prednisone, was approved based on results from the Phase 3 Tropic clinical study involving 755 patients with mHRPC previously treated with

Data from the phase III Tender study showed that, following three months’ treatment with RoActemra, 85% of patients achieved 30% improvement (JIA ACR30) in the signs and symptoms

FDA warned the consumers who had already faced adverse reactions from penicillin products and said that they are at risk of experiencing similar reactions from cloxacillin. This includes

In the trial, the difference was driven by a decrease in hemoglobin and/or hematocrit of defined or presumed GI origin. Pfizer claimed that Condor (Celecoxib vs Omeprazole and